Form 4 for BCDA BioCardia, Inc.

Accepted 2025-04-25 00:00:00 ET · period of report 2025-04-23 · accession 0001437749-25-013198 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2025-04-25	2025-04-23	BCDA	Blank Andrew Scott	Dir	P - Purchase	$1.91	+131.2K	266.0K	+97%	+$250.7K
DI	2025-04-25	2025-04-23	BCDA	Blank Andrew Scott	Dir	P - Purchase	—	+131.2K	242.2K	+118%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-04-23	P	A	131,233	$1.91	265,957	I See Footnote	—	—	(F1) On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. (F2) These shares are held by Andy Blank Revocable Living Trust, of which the Reporting Person serves as trustee.
2	Derivative	Warrant (right to buy)	2025-04-23	P	A	131,233	—	242,233	I See Footnote	$1.91 · 2025-04-23 to 2030-04-23	131,233 Common Stock	(F1) On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. (F2) These shares are held by Andy Blank Revocable Living Trust, of which the Reporting Person serves as trustee.